[ 11 C]Carbon monoxide is an appealing synthon for introducing carbon-11 at a carbonyl position (C=O) in a wide variety of chemotypes (e.g., amides, ketones, acids, esters, and ureas). The prevalence of the carbonyl group in drug molecules and the present-day broad versatility of carbonylation reactions have led to an upsurge in the production of this synthon and in its application to PET radiotracer development. This review focuses on the major advances of the past 15 years.
By comparison, a single dose of a PET radiotracer for an experiment in a human subject is about 400 MBq. In our experience, a radiotracer A m that is greater than 40 GBq/μmol is acceptable for most PET experiments (Dahl et al. 2018) . Arbitrarily, the following qualitative description scale for A m (GBq/μmol) values has been used in this review: 5-50 GBq/μmol: low; 50-100 GBq/μmol: moderate; 100-200 GBq/μmol: good; 200-400 GBq/μmol: high; 400 GBq/μmol or above: very high.
Carbon-11 is generally produced with a cyclotron by proton bombardment of nitrogen gas according to the 14 N(p,α) 11 C nuclear reaction. Bombardment in the presence of oxygen (0.5-1%) or hydrogen (5-10%) gives [ 11 C] carbon dioxide or [ 11 C] methane, respectively. Oxygen or hydrogen can be present after [ 11 C] carbon dioxide and [ 11 C]methane production, respectively. Oxygen and potential radioactive impurities (e.g., oxygen-15) can be removed by concentrating the cyclotron-produced [ 11 C] carbon dioxide in a cryogenic trap (at liquid nitrogen or argon temperature) or over activated molecular sieves, placed after the output of the cyclotron target chamber. Hydrogen can be eliminated by trapping the cyclotron-produced [ 11 C] methane in a Porapak column cooled to liquid nitrogen temperature (Landais and Finn 1989) . Furthermore, it is necessary to consider possible traces of water in the target gas and in any subsequently used inert delivery gas (e.g., helium). These traces can affect the outcome and reproducibility of subsequent radiolabeling reactions but can be eliminated with a phosphorous pentoxide trap positioned before a reaction apparatus (Landais and Finn 1989 C-labeling of functionalized molecules (Miller et al. 2008; Rotstein et al. 2013 ; Taddei and Gee 2018) and underpin fast progress in new PET radiotracer development. Examples of recently developed [ [ 11 C] Carbon monoxide was early described (Clark and Buckingham 1971) but its emergence as a useful radiochemical synthon was relatively slow to follow. Interest has iii) Ag at 350°C; iv) I 2 at 700-725°C; v) S 8 /sand at 500°C or P 2 S 5 /sand at 400°C; vi) AgOTf at 160-200°C; vii) CoF 3 at 270°C; viii) CuCl 2 on pumice at 380°C; ix) 2% O 2 , Fe at 300°C; x) NH 3 /Pt at 920°C C-labeled ketones in 36-62% isolated yields. In some settings, this method has provided near quantitative yields over many repeated runs (Dahl et al. 2015a ). However, this method requires regular column maintenance and its operational success depends on the quality of the zinc. Without adequate maintenance, yields become irreproducible due to formation of zinc oxides on the metal surface over successive heating cycles. Performance may also vary unpredictably with each batch of zinc. Furthermore, the temperature required for reducing [ 11 C] carbon dioxide (400°C) is close to the melting point of zinc (420°C). Therefore, accidental overheating of the zinc column must be avoided. With the aim of developing a more convenient, efficient, and reproducible [ 11 C] carbon monoxide synthesis, molybdenum heated to 850°C was introduced as an alternative reductant (Zeisler et al. 1997) . [ 11 C] Carbon monoxide was obtained in up to 80% yield and with high A m (up to 555 GBq/μmol), corrected to the end of radioisotope production (ERP). The produced [ 11 C] carbon monoxide was used to synthesize [ 11 C] benzophenone with a non-isolated yield of up to 81%. A molybdenum column, although needing to be heated to a much higher temperature, requires less and easier maintenance than a zinc column, and gives acceptably high and more reproducible yields (up to 71%) (Dahl et al. 2015a ). These features have allowed the molybdenum method to be widely adopted for the production of [ 11 C] carbon monoxide.
Recently, the use of solid-supported zinc has been reported for improving the 'gasphase' reduction of [ 11 C] carbon dioxide to [ 11 C] carbon monoxide (Dahl et al. 2017b ).
Molecular sieves, fused silica (originally in the form of silica gel), and molybdenum were investigated as solid supports with fused silica proving to be preferred. The use of a heated column of zinc supported on fused silica at 485°C (Fig. 2, d ) gave an impressive yield (93 ± 3%; n = 20). This approach overcame the main limitations of fast deactivation and potential zinc metal melting, experienced with the traditional heated zinc column. The generated [ 11 C] carbon monoxide was tested in a 11 C-carbonylation reaction yielding the corresponding 11 C-labeled product in 72% yield but with a rather low A m of 11 GBq/μmol (Dahl et al. 2017b ). Developments to improve the A m from this method are needed for regular radiotracer synthesis applications. Nonetheless, this advance signifies an attractive direction for developing effective 'gas-phase' [ 11 C]carbon monoxide production methods. A common requirement of these 'gas-phase' production methods is for fixed dedicated equipment to occupy valuable hot cell space on a long-term basis. Therefore, alternative 'wet' methods for [ 11 C] carbon monoxide synthesis using portable apparatus have been sought, as follows.
Over the past 15 years, many 'liquid-phase' methods to produce [ 11 C] carbon monoxide have been developed as alternatives to the 'gas-phase' methods. These methods aim to avoid the dedicated equipment needs of the 'gas-phase' methodologies and to further amplify the utility of [ 11 C] In non-radiochemical studies, silacarboxylic acids have been shown to degrade upon heating or in the presence of a base or a fluoride ion source to eliminate carbon monoxide (Brook 1955; Brook and Gilman 1955; Friis et al. 2011 (Fig. 4, a) . The generated [ ]esters, were produced in this manner. Moderate yields (> 30%) and A m in the 70-499 GBq/μmol range were achieved (Taddei et al. 2015; Nordeman et al. 2015; Bongarzone et al. 2017) .
The use of lithiosilanes enables [ 11 C]carbon monoxide to be produced in a simple twovial set-up under mild reaction conditions. This overcomes the need for dedicated and fixed infrastructure in the conventional 'gas-phase' methods. However, limitations of this methodology are the rather lengthy preparation of fresh lithiosilane before [ 11 C]carbon dioxide production, reagent instability, and reactivity with atmospheric carbon dioxide. These can negatively affect the [ Disilanes have been found to react with carbon dioxide in the presence of a fluoride ion source to yield the corresponding disiloxane with the elimination of carbon monoxide (Lescot et al. 2014) . Disilanes are now considered to be compounds that are able to produce [ 11 C] carbon monoxide while overcoming some of the constraints of the [ 11 C]silacarboxylic acids methodology. 1,2-Dimethyl-1,1,2,2-tetraphenyldisilane was initially chosen for method development. Different fluoride ion sources and solvents were explored leading to TBAF and THF as the optimal activator and reaction medium for the process, respectively. Use of 0.1 equivalent of TBAF was found to be optimal for maximal [ 11 C] carbon monoxide production. The [ 11 C] carbon monoxide yield increased from 32% to 59% by optimizing the flow rate of the carrier gas for the delivery of [ 11 C] carbon dioxide into the reaction system.
Other disilanes have also been investigated. 1,1,2,2-Tetramethyl-1,2-diphenyldisilane gave a maximal [ 11 C] carbon monoxide yield of up to 74% at RT within 10 min from ERP ( Fig. 4, b) . The generated [ 11 C] carbon monoxide was used in 11 C-carbonylation reactions yielding radiolabeled products in high yield and with an A m in the 100-120 GBq/μmol range (Taddei et al. 2017a C] carbon monoxide is recirculated through the reactor was the first to be introduced (Lidström et al. 1997) . The introduction of high-pressure miniature autoclaves quickly followed (Kihlberg and Långström 1999; Hostetler and Burns 2002; Kihlberg et al. 2006) . If needed, these could be operated at high temperature (~200°C). Such autoclaves are still in use. A high-pressure (~3.5 MPa) apparatus was reported to trap [ 11 C]carbon monoxide in organic solvents with high efficiency (generally > 90%) allowing the 11 C-labeling of various chemotypes in good yields (> 37%) (Dahl et al. 2015a ). Moreover, loop reactors and micro-autoclaves enable efficient [ 11 C]carbon monoxide utilization because the volume ratio of gas-phase to solution-phase within the reactor can be kept small (Eriksson et al. 2004 (Eriksson et al. , 2006 (Eriksson et al. , 2007 .
A further notable advance has been the use of xenon to carry [ 11 C] carbon monoxide efficiently into reaction media. Xenon is highly soluble in organic solvents, such as THF (Gibanel et al. 1993) , and its use as delivery gas avoids undesirable build-up of pressure in the reaction vessel ).
In addition to the development of improved synthesis apparatus, several compounds able to trap and then release [ 11 C] (Kealey et al. 2009 (Kealey et al. , 2014a (Kealey et al. , 2014b 
Carbon monoxide is an appealing synthon for labeling a vast array of radiotracer chemotypes ( Fig. 7) because of the broad versatility of modern transition-metal mediated carbonylation reactions (Brennführer et al. 2009 ; Gadge and Bhanage 2014; Cornilleau et al. 2015; Nielsen et al. 2018) . Over the past 15 years, the radiochemistry of [ 11 C]carbon monoxide has been widely investigated and expanded (Kealey et al. 2014b; Rahman 2015; Rotstein et al. 2016) . Herein are summarized some of the latest advances in the use of [ 11 C]carbon monoxide in Pd-mediated reactions, UV-promoted reactions, and other transition metal-mediated reactions for the synthesis of a vast variety of [carbonyl- 11 C]compounds (e.g., 11 C-labeled ureas, amides, esters). [ 11 C] Carbon monoxide has been recognized as a potentially attractive alternative to Xenon was used to carry the [ 11 C] carbon monoxide into a septum-sealed glass reactor. (Åberg and Långström 2012) .
In another study, Pd(II)-mediated reactions were used to synthesize [ 11 C] (Dahl et al. 2014) .
Another approach for producing [ 11 C] amides is a quick (5 min) one-or two-pot Pd-mediated 11 C-carbonylation reaction between an aryl halide and a lithiated amine that has been freshly prepared from amine and n-butyllithium. Eleven [ (Fig. 10) (Ishii et al. 2015) . The conversion of [ 11 C] methyl esters into the corresponding [ 11 C]carboxylic acids or [ 11 C] amides was easily achieved through treatment with sodium hydroxide or aqueous ammonium, respectively (Fig. 10 ). This approach was also applied to the synthesis of [carbonyl- 11 C] aspirin and [carbonyl- 11 C] salicylic acid in yields of 15 ± 2% and 58 ± 5%, respectively. These yields surpass those obtained via the direct 11 C-carboxylation of Grignard reagents (Sasaki et al. 1999 ).
Diaryliodonium salts have featured prominently as reactive precursors for radiohalogenation reactions (Pike 2018; Telu et al. 2019) . They are also known to undergo Pd(II)-mediated carbonyl insertion with [ from a previously reported gas-liquid annular flow microfluidic apparatus (Miller et al. 2011 ). This improvement was attributed to the larger gas-liquid interface in the segmentedflow because of the continuous formation of microbubbles (Dahl et al. 2015b ). Generally, Pd-mediated carbonylation reactions are limited to compounds that lack β-hydrogens on saturated sp 3 carbons, such as aryl halides or triflates. Compounds with β-hydrogens do not produce carbonylated products with carbon monoxide because the β-hydride elimination from σ-alkyl-Pd intermediates is competitive and usually predominant (Fig. 14) . To circumvent this issue, a high-pressure reactor with a quartz window open to light from a mercury lamp has been used successfully for radical 11 C- carbonylations of substrates bearing β-hydrogen atoms (Fig. 15, a) (Itsenko et al. 2004 ). Radical 11 C-carbonylation has also been improved recently by using a low-pressure xenon-[ 11 C] carbon monoxide delivery unit and azobisisobutyronitrile (AIBN) as a radical initiator under thermal conditions (Fig. 15, b ). This approach showed broad substrate compatibility with alkyl iodides containing β-hydrogen atoms. The desired [ 11 C] amides were obtained in 9-25% isolated yields and with an A m of 101 ± 13 GBq/ μmol (Chow et al. 2016 ).
Transition-metals other than palladium have been used to mediate 11 C-carbonylation reactions. One example is the nickel(0)-mediated 11 C-carbonylation on non-activated alkyl iodides bearing a β-hydrogen atom (Fig. 16). [ 11 C] Alkyl amides were obtained in 33-57% yields within 5 min when using tert-butanol as solvent (Rahman et al. 2016 
( Fig. 17, a) (Åberg and Långström 2011 (Lohith et al. 2014; Nabulsi et al. 2016; Lohith et al. 2017; DiFilippo et al. 2019 ).
In our laboratory, we have found that normal methods for radiotracer purification (e.g., HPLC) are capable of reducing Pd residues to sub-ppb levels (e.g., for the [ 11 C]FPEB synthesis (Lohith et al. 2014) ). These levels are well below the limits considered Additional considerations pertain to 11 C-carbonylation reactions for PET radiotracer synthesis, such as steric constraints adjacent to carbonylation sites, functional group tolerance in more structurally elaborate substrates, and ease of product purification. Moreover, the overall efficiency of the production process of a PET radiotracer, from cyclotron radioisotope production to the radiochemically pure product ready for intravenous injection, is also an important aspect to consider. Ideally, the process should be readily amenable to automation. Henceforth, we summarize the progress that has been made towards producing PET radiotracers through reactions with [ 11 C]carbon monoxide. The microfluidic apparatus described earlier has been tested for the syntheses of PET radiotracers. The liquid-liquid phase microreactor featuring the copper complex (Cu(Tp * )), was implemented to synthesize a 11 C-labeled Okubo et al. 1999) . [Carbonyl- 11 C] raclopride and [carbonyl- 11 C] FLB 457 (Entries 2 and 3) have been synthesized in a gas-liquid phase segmented microreactor through Pd-mediated 11 C-carbonylation reactions (Fig. 18, b) . High non-isolated yields of [carbonyl- 11 C] raclopride and [carbonyl- 11 C] FLB 457 (79 ± 1% and 61 ± 4%, respectively) were obtained from utilized [ 11 C] carbon monoxide (Dahl et al. 2015b) . A series of model [carbonyl- 11 C] amides were produced similarly in the same study and had moderate A m (40-54 GBq/μmol).
[carbonyl- 11 C]Raclopride has also been produced through a one-step 11 C-carbonylation reaction at atmospheric pressure using Pd 2 (π-cinnamyl)Cl 2 as catalyst and Xantphos as (Rahman et al. 2015) . This similarity argues against demethylation as being a prime route of radiotracer metabolism; more likely is that amide hydrolysis occurs. It has been reasoned that two potentially slow steps in the Pd-mediated 11 C-carbonylation of aryl halides (Fig. 19) , namely activation of the Pd catalyst and subsequent oxidative addition of the aryl halide, can be beneficially avoided by pre-synthesis and isolation of the desired Pd-aryl oxidative addition complex (Aryl)Pd(X)L n . This was confirmed with the 11 C-aminocarbonylation of an isolated Pd-aryl oxidative addition complex, formed from Pd(dba) 2 and Xantphos, for the synthesis of [carbonyl- 11 C]raclopride ( Fig. 20) . This radiotracer was obtained in 38-44% yield from trapped [ C]JNJ 31020028, were also efficiently radiolabeled from pre-formed Pd-complexes.
The synthesis of selective and potent PET radiotracers for translocator protein (TSPO), a biomarker for neuroinflammation, is of continuing major interest (Dupont et al. 2017) . The TSPO radioligand, [O-methyl- 11 C]DAA1106 (Zhang et al. 2003) , has found quite wide application in clinical research. The 11 C-labeling of DAA1106, and some of its analogues has been achieved through Pd-mediated 11 C-aminocarbonylation reactions. A strong base, such as n-butyllithium, was used to activate the amine and improve the overall yields. [carbonyl- 11 C] DAA1106 (Entry 4) was produced in 30% yield and with a high A m of 455 GBq/μmol at 36 min after ERP (Fig. 21, a) (Fig. 21, b ) (Donohue et al. 2008 ). This radiotracer was studied and compared with the 18 F-labeled version in monkey. Each radiotracer gave high proportions of CB 1 specific binding in brain (Finnema et al. 2009 (Terry et al. 2010) ).
Changes in brain cholinergic neurons are implicated in several neurodegenerative disorders. Vesicular acetylcholine transporter (VAChT) is considered a biomarker for cholinergic neurons. The need of potential PET radiotracers for VAChT has been addressed in the synthesis of a small library ([ 11 C] 5a − f, Fig. 22 ) of potential VAChT radiotracers (Bergman et al. 2014) . Six piperazine-based radiotracers were produced through Pd-mediated 11 C-carbonylation insertions between synthesized amines and commercially available aryl iodides in isolated yields of 4-25% from starting radioactivity and with A m in the 124-597 GBq/μmol range. Two of these radiotracers exhibited specific binding to VAChT in vitro. However, these results did not support further evaluation of these radiotracers in pre-clinical PET imaging. The metabotropic glutamate subtype-1 receptor (mGluR1) has been implicated in anxiety and mood disorders. Therefore, mGluR1 has gained interest as a potential drug target. A Pd-mediated [ 11 C] carbon monoxide insertion reaction has been used to produce [ 11 C] FIMX as a potential PET radiotracer for imaging brain mGluR1 (Hong et al. 2015) . (Fig. 23) . [ 11 C]FIMX was obtained ready for intravenous injection in an overall yield of about 5% from initial Taddei and Pike EJNMMI Radiopharmacy and Chemistry (2019) 4:25 cyclotron-produced radioactivity and with an A m of 102 ± 31 GBq/μmol at 42 ± 3 min from ERP. PET imaging in monkey showed [ 11 C] FIMX to be an effective radiotracer for mGluR1 and to have imaging properties very similar to those of [ 18 F]FIMX (Hong et al. 2015; Xu et al. 2013) . A potential advantage of the 11 C-label over the 18 F-label is the possibility for two PET measurements in a single subject in 1 day. This possibility is convenient for drug occupancy studies which may require a series of paired baseline and pharmacological challenge experiments in single subjects. The synthesis of PET radiotracers for histone deacetylase 6 (HDAC6) has gained interest because of the possible involvement of this enzyme in cancer and various neuropsychiatric disorders (Wey et al. 2016) . A hydroxamic group features prevalently in many inhibitors of this enzyme. The HDAC6 inhibitor, tubastatin A, has been radiolabeled with carbon-11 (Entry 7) in the hydroxamic acid group via a two-step process (Fig. 24) , namely: 1) Pd-mediated [ 11 C] carbon monoxide insertion between an aryl iodide and p-nitrophenol, and 2) ultrasound-assisted hydroxyaminolysis of the preformed [
11 C]ester with excess hydroxylamine in the presence of the strong phosphazene base P 1 -t-Bu (Lu et al. 2016) . [ Trapping efficiency was about 60%. Biodistribution and PET-CT studies were performed on healthy rat brain sections and male rats, respectively. However, these studies showed low specific binding of [ 11 C] BSI-IV to BACE-1 in vitro, fast clearance in vivo, in monkey demonstrated that this radiotracer is effective for quantifying OGA in monkey brain. The histamine type-3 receptor (H 3 R) has been considered a drug target for treating neuropsychiatric disorders. Novel amide ligands for H 3 R, have been radiolabeled through Pd-mediated 11 C-aminocarbonylation reactions and evaluated with PET in monkeys (Dahl et al. 2018 (Dahl et al. 2018) .
[carbonyl-11 C]AZ13198083 (Entry 11) (Fig. 27, a) had first been reported in 2013 (Dahl et al. 2013 ). In the later study, [carbonyl- 11 C] (Siméon et al. 2017 ). However, these radiotracers were not advanced to evaluation with PET. Recently, vemurafenib (Entry 13), a serine/threonine kinase inhibitor, has been radiolabeled with carbon-11 to assess its potential as a PET radiotracer for tumors expressing the BRAF V600E mutation. Labeling was achieved through Pd-mediated 11 C-carbonylation in 21 ± 4% yield from [ 11 C]carbon monoxide and with an A m of 55 ± 18 GBq/μmol (Fig. 27,  c) (Slobbe et al. 2017) . However, preliminary in vitro and biodistribution studies in mice suggested that [ 11 C]vemurafenib is not a suitable PET radiotracer for identifying the BRAF V600E mutation in vivo (Slobbe et al. 2017 ).
The development of PET radiotracers for soluble epoxide hydrolase (sHE), an enzyme implicated in inflammation and neuropathic pain (Shen and Hammock 2012) , may be of interest to further understand these pathophysiological processes. Recently, a urea sHE inhibitor, [ 11 C]19 (Entry 14) , has been radiolabeled through a Pd-mediated oxidative 11 C-carbonylation between an aryl amine and an aliphatic amine (Fig. 27, d ).
[ 11 C] Glutamic acid decarboxylase (GAD) is the major enzyme responsible for the synthesis of the neurotransmitter γ-aminobutyric acid (Fenalti et al. 2007 ) and dysregulation of GAD function has been implicated in neuropsychiatric disorders, such as schizophrenia (Akbarian and Huang 2006) . Attempts have been made to develop PET radiotracers for GAD to potentially elucidate its function in neuropsychiatric disorders. [ 11 C]MPATB (Entry 16), a 11 C-labeled analogue of the GAD inhibitor 3-mercaptopropionic acid, has been synthesized through a one-pot Pd-mediated 11 C-carbonylation on vinyl iodide in the presence of tert-butanol and subsequent thiol-ene reaction with thiobenzoic acid (Fig. 29) . [ 11 C] Carbon monoxide has also been used with vinyl iodide to produce racemic sidechain labeled 11 C-labeled amino acids, namely the neurotransmitter glutamate and the essential amino acid glutamine through a three-step approach: 1) Pd-mediated 11 C-carbonylation of vinyl iodide in the presence of tert-butanol or tritylamine, followed by 2) Michael addition reactions with the generated [ 11 C]acrylate and [ 11 C] acrylamide, respectively, and finally 3) acid hydrolysis ( Fig. 30) (Filp et al. 2017 (Fisher et al. 2018 ). These candidate radiotracers were evaluated with PET imaging in mice. However, they proved to be ineffective PET radiotracers because of their low entry and retention in brain following intravenous administration. Transition-metals other than palladium have been used to mediate 11 C-carbonylation reactions for the synthesis of candidate PET radiotracers. One example is the Rh-promoted 11 C-carbonylation reaction with ethyl diazoacetate and ethanol to produce [carbonyl- 11 C] diethyl malonate (Entry 18) in an isolated yield of 20 ± 7% from starting radioactivity and with an A m of 127 GBq/μmol at EOS (Fig. 32, a) (Barletta et al. 2006 ). This difunctional labeling synthon was then alkylated to produce [carbonyl- 11 C] diethyl 2,2-diethylmalonate in 50% yield as a candidate PET radiotracer. This approach is promising for the synthesis of different [carbonyl- 11 C] malonates as potential PET radiotracers (Barletta et al. 2006) . A Rh-mediated 11 C-carbonylation reaction has also been used to synthesize a 11 C-labeled agonist of non-peptide angiotensin II subtype 2 receptor (AT 2 R), a receptor (Fig. 32, b) , and then evaluated with PET in rats (Stevens et al. 2016) . [ 11 C] C21 bound specifically to prostate tumor cells expressing AT 2 R but showed rapid metabolism and excretion, limiting its use as a PET radiotracer. Nevertheless, these findings provide an impetus for further development of AT 2 R-selective PET radiotracers. Rh-Promoted 11 C-carbonylations have also been used to synthesize a candidate radiotracer for the efflux transporter P-glycoprotein (P-gp) in rats, namely [ 11 C]phenytoin ( Fig. 32, c ; Entry 20). [ 11 C] Phenytoin was produced ready for intravenous injection in an overall yield of 22 ± 4% and with an A m of 277 ± 67 GBq/μmol at the end of synthesis (Verbeek et al. 2012) . However, PET evaluation in rats showed [ 11 C] phenytoin to be a weak Pg-p substrate. Another example is the Rh-mediated synthesis of [urea- 11 C] sorafenib ( Fig. 32, d ; Entry 21), a 11 C-labeled tyrosine kinase inhibitor. [urea- 11 C]Sorafenib was obtained ready for intravenous injection in a yield of 27% ± 11% and with an A m of 30-50 GBq/μmol within 50 min (Poot et al. 2013 ).
[urea- 11 C]Sorafenib proved to be stable in in vivo. This may encourage future PET studies for tumor targeting in tumor-bearing mice.
Selenium-mediated 11 C-carbonylation reactions were early described for the synthesis of functionalized [ 11 C] carbamates (Kihlberg et al. 2002) . More recently,
[carbonyl- 11 C] Zolmitriptan (Entry 22), a serotonin 5-HT 1B/1D receptor agonist, has been prepared in an autoclave through a Se-mediated [ 11 C] carbon monoxide insertion reaction (Fig. 33 ) (Lindhe et al. 2011) . [ 11 C] Zolmitriptan was used to map binding sites in monkey brain and to characterize the regional distribution of zolmitriptan binding to 5-HT 1 receptor subtypes. This PET radiotracer showed a high proportion of binding (90%) to high-affinity sites and a discrete regional distribution in monkey brain (Lindhe et al. 2011 ). ing avenues towards attractive single-step PET radiotracer production. Furthermore, the metabolic hydrolysis of PET radiotracers that are 11 C-labeled in an ester or amide carbonyl site can lead to poorly brain-penetrant radiometabolites, such as the corresponding [ 11 C]carboxylic acids. This is especially relevant and useful for avoiding PET signal contamination when PET imaging is performed with radiotracers targeting brain proteins.
Conclusions
Candidate PET radiotracers produced from [ 11 C] carbon monoxide have so far advanced only to evaluation in animals. It may be expected that in time some candidate PET radiotracers, synthesized through 11 C-carbonylation reactions, will justify their production for PET imaging in human subjects. To encourage further progress in this direction, there is a need for commercially available automated radiosynthesis apparatus specific for [ 11 C] carbon monoxide production and utility and which provides a high level of consistent performance, especially in a CGMP (current good manufacturing practice) environment. 
